John McNeil, MD, an associate professor in the Department of Anesthesiology, was awarded a grant to study whether microplastics and PFAS (forever chemicals) are building up in human heart valves & potentially causing valvular atherosclerotic disease. 📘 bit.ly/47o35lk

What can *genetic insensitivity to opioids* teach us about endogenous opioid function in humans? Fully funded position in Oslo (PhD student or postdoc) Please RT Interested in pain, mu/kappa opioids, behavioural genetics, RCTs, or related? Apply here: 2411.webcruiter.no/Main2/Rec…

Postdoc job alert! I’m looking for someone with a PhD in neuroscience/psychology, psychiatry, biomed engineering, computational modeling or a related field to join my NIH-funded team at UCLA studying the neural & computational mechanisms of #interoception in anorexia nervosa 1/2

We're looking for therapists to come work with us at the most comprehensive psychedelic research center in the world!

Do you want to capture health behavior as it happens? My summer institute on EMA is coming up at the end of this month. Spots are limited - don't miss out! @JohnsHopkinsDMH @JohnsHopkinsSPH

NIH Brain Initiative funded multiple studies on closed loop brain stimulation for a number of neuro/pscyh conditions including Parkinson Disease. Now FDA approval granted for device that adjusts stimulation based on a person's neural activity. medpagetoday.com/neurology/p…

Researchers at Johns Hopkins University are seeking individuals with chronic low back pain and co-occurring depression to participate in a research study looking at the effects of psilocybin, a psychoactive substance found in naturally occurring mushrooms. The study will investigate the psychological effects of psilocybin, including whether or not it can help with chronic low back pain and co-occurring depression. Follow the link to learn more! hopkinspsychedelic.org/backp…

Excited to announce a clinic for individuals experiencing difficulties following a psychedelic experience. I believe this is the first clinic of its kind in the US and is right here at @HopkinsMedicine, where we aim to learn about & address the benefits & risks of psychedelics 🧵

Join the world’s premier psychedelic research center! My lab at @JHPsychedelics is hiring 3 Research Program Coordinators. We're looking for talented, hard-working, rigorous emerging scientists to contribute to scientific studies, including psychedelic admin trials. Links:

#SchulichMedDent professor David Seminowicz (@daspainbrain) and team have identified two biomarkers that could revolutionize how we understand and treat chronic pain. Published in @JAMANeuro. Read more: brnw.ch/21wQhSo @umdentistry @neuraustralia #ChronicPain

Do you know anyone with chronic back pain? Has it caused other issues, such as depression, social withdrawal, unemployment, and/or substance use? I am conducting an NIH funded clinical trial to help determine whether psilocybin can help to break this downward spiral and how

We are seeking individuals with chronic low back pain and co-occurring depression to participate in a research study looking at the effects of psilocybin, a psychoactive substance found in naturally occurring mushrooms. The study will investigate the psychological effects of psilocybin, including whether or not it can help with chronic low back pain and co-occurring depression. Learn more at hopkinspsychedelic.org/backp…

The Cannabis and Health Research Initiative will help integrate medicinal cannabis in healthcare. Correspondence from Johannes Thrul & Ryan Vandrey @HopkinsMedicine nature.com/articles/s41591-0…

A new meta-analysis, in press, from @drjthrul et al, using data from the @CJFerguson1111 analysis, finds that "interventions of less than 1 week resulted in significantly worse mental health outcomes (d=-0.168, SE=0.058, p=.004), while interventions of 1 week or longer resulted in significant improvements (d=0.169, SE=0.065, p=.01)." Researchers and journalist should stop saying that the evidence is "just correlational." There is experimental evidence too. We can certainly debate what this all means, but there is a body of experiments that points, pretty consistently, to benefits from reducing social media use, as long as the reduction goes on long enough to get past withdrawal effects. You can't combine the one-day abstinence studies (which produce negative mood and well-being effects) with the studies that run for at least 2 weeks (which find benefits) and say that there is no effect, on average. It is just not right to tell young people that quitting or reducing social media will not have any effect on their mental health, according to the academic literature. osf.io/preprints/psyarxiv/de…

In our latest paper, we emphasize the need for quantitative summaries of adverse events data to complement anecdotes and drive discourse on the risks and benefits of psychedelic research.

It’s high time the field of psychedelic research move beyond the mystical experience construct (MEQ). While many critiques of the measure rest on misconceptions, persistent misunderstandings & psychometric limitations lead us to recommend transcending it.

Two new tenure-track jobs at #Dartmouth in Cognitive Science and Social Neuroscience!! And hopefully a 3rd senior TT position this year. Please help spread the word. Here's the posting for the Cog Sci position: apply.interfolio.com/152809

Friend & neuroscience bada$$ @FadelZeidan and his @UCSDHealth colleagues are conducting research on experimental treatments for CRPS. If you have CRPS or know someone who does, and are interested in participating, give them a holler👇🏼👇🏼👇🏼 #crps #chronicpain

Researchers at Johns Hopkins University are seeking individuals with chronic low back pain and co-occurring depression to participate in a research study on the effects of psilocybin and whether or not it can help with chronic low back pain and co-occurring depression. Email us at LowBackPain@jh.edu or visit the link below to apply! hopkinspsychedelic.org/backp… Principal Investigator: David B. Yaden, Ph.D. Protocol: IRB00385932